We reviewed selected reports in the field of basic and clinical immunology published in 2008.
Basic and clinical immunology have been redefined by developments in next-generation sequencing and genome editing techniques [ 14].
The following subject categories are covered: basic and clinical immunology, carcinogenesis, cell, molecular, and stem cell biology, clinical research, drug discovery and delivery, epidemiology and prevention, genetics, genomics, and proteomics, infl ammation and virology, and pathology.
The following subject categories are covered: basic and clinical immunology, carcinogenesis, cell, molecular, and stem cell biology, clinical research, drug discovery and delivery, epidemiology and prevention, genetics, genomics, and proteomics, inflammation and virology, and pathology.
In this special issue, we take an interest from mathematicians, bioinformaticians, computational scientists, and engineers together with experimental immunologists, to present and discuss latest developments in different subareas ranging from modeling and simulation to machine learning predictions and their application to basic and clinical immunology.
All probands attended the Rheumatology and Clinical Immunology Clinics at the University of Santo Tomas Hospital, Manila, Philippines.
Her father is a professor of medicine and the chief of the rheumatology and clinical immunology division at the University of Maryland School of Medicine in Baltimore.
The report, published earlier this year in The Journal of Allergy and Clinical Immunology, was prepared by researchers from the Mayo Clinic in Rochester and researchers from a hospital in Madrid.
In the Zeiger study, which appeared in The Journal of Allergy and Clinical Immunology, mothers prone to allergy were randomly assigned a restricted diet.
"It's a question of how bad a placebo effect you have," says Dr. Peter S. Creticos, head of the allergy and clinical immunology division at the Johns Hopkins University School of Medicine.
A committee for the American Academy of Asthma Allergy and Immunology is considering revised guidelines recommending earlier introduction of foods like eggs, peanuts and shellfish, which in the past have been delayed until age 2 or 3. A 2008 study of 10,000 British children, reported in The Journal of Allergy and Clinical Immunology, found that early exposure to peanuts lowered allergy risk.
